drugset / Trial / NCT00496574

Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

NCT00496574 ↗

Phase 4 Unknown 60 enrolled Medical University of Lodz
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy after three years of SIT in children with asthma.

Timeline

Start
2006-05
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Novo Helisen Depot Other / unclassified — Subcutaneous
Comparator Phostal Unknown — Subcutaneous

Indications